Editor’s Note: Related Tickers: MannKind Corporation (NASDAQ:MNKD)
MannKind shares decline by 4.10% (NYSE POST)
The stock had moved on to decrease by 4.10% to close at $7.95 on Monday, after the opening price at $8.29 per share. MannKind Corporation (NASDAQ:MNKD) had throughout the trading session moved between $7.91 and $8.29 per share and presently has 52 week lowest price at $1.82 and 52 week highest price at $8.33 per share. The market cap of the stock is at $2.31 billion with 290.88 million shares outstanding and 18% institutional ownership of capital. The trading volume on Monday was at 9.63 million shares on the stock and the average level is at 6.32 million shares per day.
Most Volatile Alert – MannKind Corporation, Allied Nevada Gold Corp., MeetMe Inc, EXCO Resources Inc (SBWire)
MannKind Corporation (NASDAQ:MNKD) opened the session at $7.37, remained amid the day range of $6.84 – $8.03, and closed the session at $7.36. The stock showed a negative performance of -7.36% in previous trading session. The stock gained a volume of 8.14 million shares and the average volume of the stock remained 6.15 million shares. MannKind Corporation is a development-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer.
Insider Selling: MannKind Corporation CFO Sells 10,000 Shares of Stock (Daily Political)
MannKind CFO Matthew Pfeffer sold 10,000 shares of MannKind Corporation stock in a transaction that occured on Thursday, August 1st. The shares were sold at an average price of $8.00, for a total value of $80,000.00. Following the sale, the chief financial officer now directly owns 83,654 shares in the company.